Big Pharma makes HUGE payments to peer reviewers in major medical journals

A new research letter published in the Journal of the American Medical Association (JAMA) revealed that most peer reviewers for medical journals are given industry payments.

Author: Cassie B.

Natural News Oct 22, 2024

The payments, which are given to physicians who conduct peer reviews by drug and medical device makers, totaled $1.06 billion across the three years studied.

This is clearly a conflict of interest, and while journals often have conflict-of-interest policies that are applied to authors, very few hold peer reviewers to the same standard.

The researchers looked at the general and research payments that doctors serving as peer reviewers for major journals were given by drug and device manufactures from 2020 to 2022.

Some of the publications studied included The LancetThe New England Journal of MedicineBMJ and even JAMA, who published the research letter.

University of Toronto urology resident physician David-Dan Nguyen, who authored the study, said: “Although conflicts of interest of journal editors and authors have been investigated, the traditionally opaque nature of peer review has hindered their evaluation among peer reviewers, despite their crucial role in academic publishing.”

They studied the peer reviewer lists of each journal and compared it to information from the Open Payments database about general and research payments. More than 7,000 reviewers were initially listed, but this was narrowed down to 1,962 after excluding those who were not physicians or were not located in the U.S.

They found that nearly 59% of the reviewers were given at least one industry payment during the period studied. Among this group, more than half received general payments and 31.8% received research payments.

The money awarded included more than $1 billion given to individuals or their institutions, more than $64 million in general payments, $11.8 million in speaking compensation fees and more than $34 million in consulting fees.

Peer reviewers rake in thousands of dollars from pharmaceutical companies

Just how much is a peer review worth in today’s market? The researcher found that the median research payment was a generous $153,173, while the median general payment was $7,614. There was a notable divide across genders, with male reviewers enjoying a median total payment of $38,959 versus $19,586 for women; the difference in general payments was a median of $8,663 for male reviewers versus $4,183 for female reviewers. The payments also varied by specialty, with some earning significantly more than others.

The authors pointed out that they did not consider payments from entities such as technology and insurance companies, which means they could be underestimating the payments reviewers are given.

Many times, studies are considered more reliable if they bear the “peer reviewed” label, but research like this shows us how little the term really means.

“Peer reviewers act as critical arbiters of both the validity and relevance of peer-reviewed studies. Therefore, understanding the potential intellectual and financial relationships that may affect their decision making is key to understanding how these influences affect the peer-reviewed literature,” said study co-author Dr. Christopher Wallis of the University of Toronto.

Unbiased information about medical care is hard to find

These days, it’s hard to find unbiased information about medical care; even doctors aren’t reliable as they increasingly receive kickbacks from pharmaceutical companies for prescribing their drugs.

One study by ProPublica found more than 700 doctors who had received at least $1 million in kickbacks from pharmaceutical companies, raising doubts about what motivates them to prescribe a drug and whether it is truly needed in every case they write a prescription for it.

Sources for this article include:

JAMANetwork.com

Healio.com

MedPageToday.com

ProPublica.org

Source

Uncensored is being censored
Get your copy from our Online Store or your local book and magazine retailer
Australian Retail Locations » Uncensored Publications Limited
New Zealand Retail Locations » Uncensored Publications Limited
As censorship heats up and free thought becomes an increasingly rare commodity, we appeal to our readers to support our efforts to reach people with information now being censored elsewhere. In the last few years, Uncensored has itself been censored, removed from the shelves of two of our biggest NZ retailers – Countdown Supermarkets and Whitcoulls Bookstores – accounting for 74% of our total NZ sales.
You can help keep the Free Press alive by subscribing and/or gifting a subscription to your friends and relatives.

Martin Harris

I have a lovely partner and 3 very active youngsters. We live in the earthquake ravaged Eastern Suburbs of Christchurch, New Zealand. I began commenting/posting on Uncensored back in early 2012 looking for discussion and answers on the cause and agendas relating to our quakes. I have always maintained an interest in ancient mysteries, UFOs, hidden agendas, geoengineering and secret societies and keep a close eye on current world events. Since 2013 I have been an active member of theCONTrail.com community, being granted admin status and publishing many blogs and discussion threads. At this time I'm now helping out with admin and moderation duties here at Uncensored where my online "life" began.

Leave a Reply

Your email address will not be published. Required fields are marked *

Next Post

Woke doc refuses to publish $10 million trans kids study that showed puberty blockers didn't help mental health

Fri Oct 25 , 2024
A prominent doctor and trans rights advocate admitted she deliberately withheld publication of a $10 million taxpayer-funded study on the effect of puberty blockers on American children — after finding no evidence that they improve patients’ mental health. Chris NesiNew York PostWed, 23 Oct 2024 © Michael Tullberg / Getty […]
Puberty blockers

You May Like

//